菌体治疗:从生物机制到未来的方向
Steffanie A Strathdee1, Graham F Hatfull2, Vivek K Mutalik3
1Center for Innovative Phage Applications and Therapeutics, Division of Infectious Disease and Global Public Health, University of California, San Diego, La Jolla, CA 92093-0507, USA.
Cell
|January 7, 2023
概括
使用天然的细菌捕食者进行的菌体 (菌体) 治疗由于抗菌素耐药性增加而越来越受欢迎. 本综述涵盖了菌体机制,应用和有效治疗开发的挑战.
科学领域:
- 微生物学
- 生物技术
- 传染性疾病
背景情况:
- 抗菌药物耐药性的增加需要新的治疗策略.
- 菌体 (菌体) 是天然的细菌捕食者,
- 菌体治疗需要仔细考虑菌体活性,宿主特异性和安全性.
研究的目的:
- 审查细菌治疗的现状.
- 讨论生物机制,临床应用和挑战.
- 探索治疗菌体发展的未来方向.
主要方法:
- 对菌体研究的综合文献综述.
- 对菌与细菌相互作用的生物机制的分析.
- 对临床数据和监管考虑的审查.
主要成果:
- 菌体对特定的细菌宿主表现出强烈的化活性.
- 成功的临床应用突显了菌体治疗的潜力.
- 挑战包括描述,交付和监管障碍.
结论:
- 菌体治疗是对抗抗菌素耐药性的有效策略.
- 进一步的研究和开发对于广泛的临床采用至关重要.
- 为了推进治疗菌体的应用,合作是必不可少的.
相关概念视频
Lytic Cycle of Bacteriophages
71.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.4K
Microorganisms in Medicine and Therapeutics
137
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
137
DNA Bacteriophages
85
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
85
Lysogenic Cycle of Bacteriophages
62.8K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.8K
Viral Replication: Lysogenic Cycle
116
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
116
Gene Therapy
25.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.7K


